Art

J-GLOBAL ID：202102280127609858   Reference number：21A1473977

Rezafungin-Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins

レザフンギン-作用,感受性および耐性の機序: 他のエキノカンジンとの類似性および差異【JST・京大機械翻訳】

Author (2)： Garcia-Effron Guillermo (Laboratorio de Micologia y Diagnostico Molecular, Catedra de Parasitologia y Micologia, Facultad de Bioquimica y Ciencias Biologicas, Universidad Nacional del Litoral, C.P. 3000 Santa Fe, Argentina) ,  Garcia-Effron Guillermo (Consejo Nacional de Investigaciones Cientificas y Tecnologicas, C.P. 3000 Santa Fe, Argentina)
Material： Journal of Fungi (Web)
Volume： 6  Issue： 4  Page： 262  Publication year： 2020 
JST Material Number： U7219A  ISSN： 2309-608X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Rezafungin (formerly CD101) is...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A1473977&from=J-GLOBAL&jstjournalNo=U7219A") }}

Thesaurus term： osmosis ,  enzyme ,  sensitivity ,  vein ,  Food and Drug Administration ,  spectrum ,  similarity ,  *in vitro experiment
Semi thesaurus term： グルカンシンターゼ ,  *エキノカンジン , 【Automatic Indexing@JST】

Author keywords (6)： rezafungin ,  CD101 ,  antifungal susceptibility ,  mechanism of action ,  mechanism of resistance ,  literature review

JST classification (1)： Basic research of antifungal drugs  (GW17060K)

Substance index (1)： Caspofungin

Reference (147)：

• Bongomin, F.; Gago, S.; Oladele, R.O.; Denning, D.W. Global and multi-national prevalence of fungal diseases-Estimate precision. J. Fungi 2017, 3, 57.
• Gobal Action Found for Fungal Infections (GAFFI). Improving Outcomes for Patients with Fungal Infections across the World. A Road Map for the Next Decade. Available online: https://www.gaffi.org/wp-content/uploads/GAFFI_Road_Map_interactive-final0415.pdf (accessed on 29 October 2020).
• Wall, G.; Lopez-Ribot, J.L. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics 2020, 9, 445.
• Gintjee, T.J.; Donnelley, M.A.; Thompson, G.R. Aspiring Antifungals: Review of Current Antifungal Pipeline Developments. J. Fungi 2020, 6, 28.
• Onishi, J.; Meinz, M.; Thompson, J.; Curotto, J.; Dreikorn, S.; Rosenbach, M.; Douglas, C.; Abruzzo, G.; Flattery, A.; Kong, L.; et al. Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors. Antimicrob. Agents Chemother. 2000, 44, 368-377.

Terms in the title (5)： 感受性 ,  耐性 ,  エキノカンジン ,  類似性 ,  差異